J. Vrona

Adding ascorbic acid to arsenic trioxide produces limited benefit in patients with acute myeloid leukemia excluding acute promyelocytic leukemia

D. Douer, L. Ramezani, A. Mohrbacher, 2014, Annals of Hematology.

Toxicity profile of repeated doses of PEG‐asparaginase incorporated into a pediatric‐type regimen for adult acute lymphoblastic leukemia

I. Aldoss, D. Douer, V. Pullarkat, 2016, European journal of haematology.

Pharmacokinetics-based integration of multiple doses of intravenous pegaspargase in a pediatric regimen for adults with newly diagnosed acute lymphoblastic leukemia.

M. Tallman, I. Aldoss, M. Lunning, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multiple Doses of Intravenous Pegylated Asparaginase with a “Pediatric-like” Protocol in Adults with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL): Toxicity, Clinical Outcome and Low Rate of Anti Asparaginase Antibody Formation.

A. Yang, D. Douer, K. Watkins, 2009 .

Toxicity profile of repeated doses of PEG‐asparaginase incorporated into a pediatric‐type regimen for adult acute lymphoblastic leukemia

I. Aldoss, D. Douer, V. Pullarkat, 2016, European journal of haematology.